NCT02587390已完成1 期
A Study to Evaluate the Effects of Gemcabene on the Steady-State Pharmacokinetics and Pharmacodynamics of Simvastatin in Healthy Volunteers
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 20
- 主要终点
- Pharmacokinetics
研究概览
简要总结
The purpose of this study is to determine the effect of gemcabene on the pharmacokinetics of simvastatin 80 mg.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Males and Females
- •>18 years of age
- •Body weight 45 kg or greater
排除标准
- •If female, of childbearing potential or lactation
- •History of significant adverse reaction to any fibrate lipid-lowering agent or HMG-CoA reductase inhibitor
研究组 & 干预措施
Gemcabene 900 mg
Experimental
Gemcabene 900 mg
干预措施: Simvastatin 80 mg (Drug)
Gemcabene 900 mg
Experimental
Gemcabene 900 mg
干预措施: Gemcabene 900 mg (Drug)
Simvastatin 80 mg
Active Comparator
Simvastatin 80 mg
干预措施: Simvastatin 80 mg (Drug)
结局指标
主要结局
Pharmacokinetics
时间窗: 15 days
Area Under the Curve (AUC)
次要结局
- Clinical Laboratory - hematology, chemistry, urinalysis(57 days)
- Adverse Events(57 days)
- ECG(57 days)
研究者
相似试验
已完成
1 期
Drug Interaction Study of Simvastatin and DabigatranHealthyNCT03728101Korea University Guro Hospital12
已完成
1 期
A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer PatientsNeoplasmsNCT00001449National Cancer Institute (NCI)60
终止
1 期
A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic CancerPancreatic CancerNCT01025570University of California, San Francisco3
尚未招募
2 期
Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic CancerPancreatic Cancer, Stage IBPancreatic Cancer, Stage IIAPancreatic Cancer, Stage IIBPancreatic Cancer Stage IIINCT05562297Shanghai Zhongshan Hospital50
已完成
2 期
MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung CancerNon Small Cell Lung CancerNCT00401492National Cancer Institute, Naples159